Literature DB >> 26500940

Inheritance of Hereditary Persistence of Fetal Haemoglobin (HPFH) in a Family of Western Odisha, India.

Siris Patel1, Snehadhini Dehury2, Prasanta Purohit3, Satyabrata Meher2, Kishalaya Das4.   

Abstract

Hereditary persistence of foetal haemoglobin (HPFH) is a rare inherited haemoglobin disorders in India. We encountered five cases of HPFH-3 in heterozygous condition in a single family of western Odisha, India. All the cases had raised % HbF (26.1±3.23%) with pancellular distribution of HbF in erythrocytes. There were no abnormalities found in the red cell indices. All the cases were asymptomatic till date with normal growth and development. Molecular confirmation of this haemoglobin disorders is important for control and prevention of haemoglobinopathies in this region.

Entities:  

Keywords:  Alpha thalassemia; HPFH; Haemoglobin

Year:  2015        PMID： 26500940      PMCID： PMC4606269          DOI： 10.7860/JCDR/2015/12878.6548

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN： 0973-709X


  8 in total

1.  Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia.

Authors:  S S Chong; C D Boehm; D R Higgs; G R Cutting
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

2.  Hereditary persistence of foetal haemoglobin in a tribal family of Orissa, India.

Authors:  R S Balgir
Journal:  Natl Med J India       Date:  2004 May-Jun       Impact factor: 0.537

3.  Molecular characterization of delta beta-thalassemia and hereditary persistence of fetal hemoglobin in the Indian population.

Authors:  Anita Nadkarni; Marukh Wadia; Ajit Gorakshakar; Ryoiti Kiyama; Roshan B Colah; Dipika Mohanty
Journal:  Hemoglobin       Date:  2008       Impact factor: 0.849

4.  Identification of rare and novel deletions that cause (δβ)0-thalassaemia and hereditary persistence of foetal haemoglobin in Indian population.

Authors:  Thiyagaraj Mayuranathan; Janakiram Rayabaram; Reena Das; Neeraj Arora; Eunice S Edison; Mammen Chandy; Alok Srivastava; Shaji R Velayudhan
Journal:  Eur J Haematol       Date:  2014-03-15       Impact factor: 2.997

5.  Hereditary persistence of foetal haemoglobin in northwest India.

Authors:  K Ghosh; S W Hasan; S Kumar
Journal:  Trop Geogr Med       Date:  1988-07

6.  Rapid detection of deletions causing delta beta thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification.

Authors:  J E Craig; R A Barnetson; J Prior; J L Raven; S L Thein
Journal:  Blood       Date:  1994-03-15       Impact factor: 22.113

Review 7.  Relationship between genotype and phenotype. Thalassemia intermedia.

Authors:  R Galanello; A Cao
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

8.  Prevalence of deletional alpha thalassemia and sickle gene in a tribal dominated malaria endemic area of eastern India.

Authors:  Prasanta Purohit; Snehadhini Dehury; Siris Patel; Dilip Kumar Patel
Journal:  ISRN Hematol       Date:  2014-03-11
  8 in total
  3 in total

1.  Analysis of deletional hereditary persistence of fetal hemoglobin/δβ-thalassemia and δ-globin gene mutations in Southerwestern China.

Authors:  Jie Zhang; Yang Yang; Peng Li; Yuanlong Yan; Tao Lv; Tingting Zhao; Xiaohong Zeng; Dongmei Li; Xiaoyan Zhou; Hong Chen; Jie Su; Tonghua Yang; Jing He; Baosheng Zhu
Journal:  Mol Genet Genomic Med       Date:  2019-05-01       Impact factor: 2.183

2.  Spectrum of hemoglobin disorders in southern Odisha, India: a hospital based study.

Authors:  Pramita Sahu; Prasanta Purohit; Santwana Mantri; Ramray Tudu; Jayanti Nayak; Sunil Kumar Agrawalla; Samira Kumar Behera; Manoj Kumar Patro; Nivedita Karmee; Diptimayee Tripathy; Bharati Mishra; Debi Prasad Mishra
Journal:  Porto Biomed J       Date:  2021-02-11

3.  Evaluation of Stem Cell-Derived Red Blood Cells as a Transfusion Product Using a Novel Animal Model.

Authors:  Sandeep N Shah; Monique P Gelderman; Emily M A Lewis; John Farrel; Francine Wood; Michael Brad Strader; Abdu I Alayash; Jaroslav G Vostal
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.